Akero shares double after preliminary results from mid-stage trial for liver disease drug
(Reuters) -Akero Therapeutics shares gained 106% before the bell on Monday after its lead drug helped patients with a type of liver disease to reverse scarring of the organ without the worsening of ...
Axios on MSN33m
Staff shakeup risks $2M+ in grants, former Des Moines mayor says
Des Moines is seeking local government and nonprofit partners to jointly apply for a $250,000 clean energy projects grant ...
As sales slump, Kohl’s turns to a new CEO to bring back customers
A new CEO took the reins at Kohl’s this month, hoping to reverse a long losing streak at America’s largest department store chain. But after years of declining sales, a sharp drop in stock value and ...